BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 12 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 12 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 12 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 13 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 13 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 14 hours ago Atmus Welcomes Heath Sharp to Board of Directors 16 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 16 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

FibroGen Inc (FGEN) Q4 2022 Earnings Call Transcript

FibroGen Inc (NASDAQ:FGEN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Michael Tung — Vice President, Corporate Strategy and Investor Relations Enrique Conterno — Chief Executive Officer…

FibroGen Inc (FGEN) Q3 2022 Earnings Call Transcript

FibroGen Inc (NASDAQ:FGEN) Q3 2022 Earnings Call dated Nov. 07, 2022. Corporate Participants: Michael Tung — Investor Relations Enrique Conterno — Chief Executive Officer Juan Graham — Chief Financial Officer Mark…

FibroGen, Inc. (FGEN) Q2 2022 Earnings Call Transcript

FibroGen, Inc.  (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung — Vice President of Corporate Strategy and Investor Relations Enrique Conterno — Chief…

FibroGen, Inc. (FGEN) Q4 2021 Earnings Call Transcript

FibroGen, Inc.  (NASDAQ: FGEN) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Michael Tung — Vice President, Corporate Strategy & Investor Relations Enrique Conterno — Chief Executive…

FibroGen Inc. (FGEN) Q1 2021 Earnings Call Transcript

FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung — Vice President of Corporate Strategy and Investor Relations Enrique Conterno — Chief…